Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study

Author:

Sunyoto TemmyORCID,Potet Julien,den Boer Margriet,Ritmeijer Koert,Postigo Jose A R,Ravinetto Raffaella,Alves Fabiana,Picado Albert,Boelaert Marleen

Abstract

ObjectivesTo understand stakeholders’ perceptions of the access barriers to quality-assured diagnostics and medicines for leishmaniasis in the high-burden region of eastern Africa, and to identify key bottlenecks to improve the supply of commodities for neglected tropical diseases.DesignDesk reviews and qualitative in-depth interview study with purposive sampling.MethodsA landscape analysis through literature and desk review was performed. Next, 29 representatives from international organisations, non-governmental agencies, national control programmes from six countries (Ethiopia, Kenya, Somalia, South Sudan, Sudan and Uganda) and manufacturers were interviewed between May and July 2018. Participants were selected purposively and expanded through a snowballing technique.Data analysis was aided by NVivo, applying the framework method as a part of the thematic content analysis approach.ResultsThe barriers along the visceral leishmaniasis (VL) supply chain were identified as emerging themes, grouped across supply chain activities and health systems component(s). Stakeholders expressed the perception of progress, but bottlenecks persist. VL medicines, in general, lack multisource production capacity and with small market volume, expansion of suppliers is difficult. Procurement is plagued by forecasting difficulties, complex regulatory policies and procedures, and distribution challenges. Weak communication and coordination across different levels resulted in shortages and loss of trust among different actors. Cross-cutting issues spanned from limited political and resource commitment due to low awareness and limited in-country capacity. However, study respondents were optimistic to pursue several remedies, most importantly to build bridges between supply and demand sides through continued dialogue and collaborations. Diagnostics supply has mostly been overlooked; thus, improved investment in this area is needed.ConclusionsAddressing supply barriers in eastern Africa requires consistent, specific efforts at the global and national levels, progressing from current partnerships and agreements. Priority actions include pooled procurement, improved forecast, and increased commitment and resources. Sustainability remains an elusive goal, yet to be integrated into discussions moving forward.

Funder

H2020 Marie Skłodowska-Curie Actions

Publisher

BMJ

Subject

General Medicine

Reference62 articles.

1. Drug development for neglected diseases: a deficient market and a public-health policy failure

2. The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment;Pedrique;Lancet Glob Health,2013

3. Access to Essential Drugs in Poor CountriesA Lost Battle?

4. Global leishmaniasis surveillance update, 1998-2016;World Health Organisation;Wkly Epidemiol Rec,2018

5. Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014;WHO;Wkly Epidemiol Rec,2016

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Outsourcing for emergency relief: Unravelling key strategies;International Journal of Research in Business and Social Science (2147- 4478);2023-12-11

2. The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018;PLOS Neglected Tropical Diseases;2022-08-18

3. Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis;Frontiers in Tropical Diseases;2022-05-12

4. Get Me a Mask! The Challenge of Equipment Supply Chains;Pediatrics;2021-09-01

5. Market Formation in a Global Health Transition;Environmental Innovation and Societal Transitions;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3